Immunological indicators of coeliac disease activity are not altered by long-term oats challenge

Clinical and Experimental Immunology

Volumn 171, Issue 3, 2013, Pages 313-318

  Cooper, S E J ^a   Kennedy, N P ^b   Mohamed, B M ^b   Abuzakouk, M ^d   Dunne, J ^a   Byrne, G ^a   McDonald, G ^a   Davies, A ^b   Edwards, C ^b   Kelly, J ^c   Feighery, C F ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^d HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coeliac disease; Immunological parameters; Oats challenge; Tissue transglutaminase

Indexed keywords

AUTOANTIBODY; KI 67 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE CELL; MALE; OAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AVENA SATIVA; CELIAC DISEASE; DIET; DIET, GLUTEN-FREE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GTP-BINDING PROTEINS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; TRANSGLUTAMINASES;

EID: 84873319821     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12014     Document Type: Article

References (35)

1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357:1731-1743.
2. Feighery C. Fortnightly review: coeliac disease. BMJ 1999; 319:236-239.
3. United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol 2001; 13:1123-1128.
4. Shewry PR. Cereal proteins and coeliac disease. In: Marsh MN, ed. Coeliac disease. Oxford: Blackwell Scientific, 1992:305-348.
5. Janatuinen EK, Pikkarainen PH, Kemppainen TA etal. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333:1033-1037.
6. Srinivasan U, Leonard N, Jones E etal. Absence of oats toxicity in adult coeliac disease. BMJ 1996; 313:1300-1301.
7. Hoffenberg EJ, Haas J, Drescher A etal. A trial of oats in children with newly diagnosed celiac disease. J Pediatr 2000; 137:361-366.
8. Hogberg L, Laurin P, Falth-Magnusson K etal. Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut 2004; 53:649-654.
9. Peraaho M, Kaukinen K, Mustalahti K etal. Effect of an oats-containing gluten-free diet on symptoms and quality of life in coeliac disease. A randomized study. Scand J Gastroenterol 2004; 39:27-31.
10. Kemppainen TA, Heikkinen MT, Ristikankare MK etal. Unkilned and large amounts of oats in the coeliac disease diet: a randomized, controlled study. Scand J Gastroenterol 2008; 43:1094-1101.
11. Holm K, Maki M, Vuolteenaho N etal. Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study. Aliment Pharmacol Ther 2006; 23:1463-1472.
12. Lundin KE, Nilsen EM, Scott HG etal. Oats induced villous atrophy in coeliac disease. Gut 2003; 52:1649-1652.
13. Arentz-Hansen H, Fleckenstein B, Molberg O etal. The molecular basis for oat intolerance in patients with celiac disease. PLoS Med 2004; 1:e1.
14. Haboubi NY, Taylor S, Jones S. Coeliac disease and oats: a systematic review. Postgrad Med J 2006; 82:672-678.
15. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol 2007; 42:171-178.
16. Feighery C, Weir DG, Whelan A etal. Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol 1998; 10:919-925.
17. Marsh MN. Mucosal pathology in gluten sensitivity. In: Marsh MN, ed. Coeliac disease. Oxford: Blackwell Scientific, 1995:136-191.
18. Mohamed BM, Feighery C, Kelly J etal. Increased protein expression of matrix metalloproteinases -1, -3, and -9 and TIMP-1 in patients with gluten-sensitive enteropathy. Dig Dis Sci 2006; 51:1862-1868.
19. Mohamed BM, Feighery C, Williams Y etal. The use of Cellomics to study enterocyte cytoskeletal proteins in coeliac disease patients. Cent Eur J Biol 2008; 3:258-267.
20. Catassi C, Rossini M, Ratsch IM etal. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 1993; 34:1515-1519.
21. Kemppainen T, Janatuinen E, Holm K etal. No observed local immunological response at cell level after five years of oats in adult coeliac disease. Scand J Gastroenterol 2007; 42:54-59.
22. Srinivasan U, Jones E, Carolan J etal. Immunohistochemical analysis of coeliac mucosa following ingestion of oats. Clin Exp Immunol 2006; 144:197-203.
23. Maiuri L, Ciacci C, Raia V etal. FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut 2001; 48:418-424.
24. Settakorn J, Leong AS. Immunohistologic parameters in minimal morphologic change duodenal biopsies from patients with clinically suspected gluten-sensitive enteropathy. Appl Immunohistochem Mol Morphol 2004; 12:198-204.
25. Mohamed BM, Feighery C, Coates C etal. The absence of a mucosal lesion on standard histological examination does not exclude diagnosis of celiac disease. Dig Dis Sci 2008; 53:52-61.
26. Powell DW, Mifflin RC, Valentich JD etal. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999; 277:C1-9.
27. Skovbjerg H, Hansen GH, Niels-Christiansen LL etal. Intestinal tissue transglutaminase in coeliac disease of children and adults: ultrastructural localization and variation in expression. Scand J Gastroenterol 2004; 39:1219-1227.
28. Gorgun J, Portyanko A, Marakhouski Y etal. Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study. Virchows Arch 2009; 455:363-373.
29. Biagi F, Campanella J, Laforenza U etal. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent. Dig Liver Dis 2006; 38:652-658.
30. Verderio EA, Johnson T, Griffin M. Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids 2004; 26:387-404.
31. Iismaa SE, Mearns BM, Lorand L etal. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 2009; 89:991-1023.
32. Verderio EA, Johnson TS, Griffin M. Transglutaminases in wound healing and inflammation. Prog Exp Tumor Res 2005; 38:89-114.
33. Kim Y, Eom S, Kim K etal. Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation. Mol Immunol 2010; 47:1010-1022.
34. Maiuri MC, De Stefano D, Mele G etal. Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients. J Mol Med (Berl) 2003; 81:373-379.
35. Vader LW, Stepniak DT, Bunnik EM etal. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003; 125:1105-1113.